GRANTS

  • GRANT
    Rab27a: A novel drug target in drug resistant and metastatic cancer.
    Cancer Research UK1 Jan 2016 - 30 Jun 2018
    CRUK: Rab27a: A novel drug target in drug resistant and metastatic cancer. (2016-2018)